SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-22-000073
Filing Date
2022-12-22
Accepted
2022-12-21 19:07:58
Documents
12
Period of Report
2022-12-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K angn-20221215.htm   iXBRL 8-K 33807
  Complete submission text file 0001601485-22-000073.txt   175957

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20221215.xsd EX-101.SCH 1987
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20221215_lab.xml EX-101.LAB 25136
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20221215_pre.xml EX-101.PRE 13128
6 EXTRACTED XBRL INSTANCE DOCUMENT angn-20221215_htm.xml XML 11421
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 221479479
SIC: 2834 Pharmaceutical Preparations